Search results for:

voriconazole iv

voriconazole IV
Brand names: Vfend
Form Strength
POWDER FOR INJECTION, INTRAVENOUS 200 mg

Display Azoles Class: 081408

Medication comments:
voriconazole should be dosed using Adjusted Body Weight for obese patients with BMI >30 kg/m2.
Per policy, these drugs are subject to renal dosing adjustments by pharmacy. 
Generic + Route
(Brand)
• Indications
Usual Adult Dose
Comments
Renal Dosage Adjustments
voriconazole IV
(Vfend©)
6 mg/kg q12h x 2 doses, then 3-4 mg/kg q12h No adjustment necessary
Per policy, these drugs may be converted from IV to PO in patients who meet criteria.  
voriconazole
(Vfend) IV
weight based dosing (3-4 mg/kg q12h) 200 mg PO q12h
fixed (non-weight based) dosing may convert from IV to PO on a mg-to-mg basis.
USP <800> Hazardous Drug Assessment of Risk (AOR)
Per policy, these drugs are exempt from USP <800> handling requirements under normal circumstances.
The following outlines must be followed.
generic (Brand) Route
[Packaging: Manufacturer ⇒ Dispense]
Activities
voriconazole (Vfend) IV
[n/a]
Stock @ IDBH? N
NIOSH Table 2B
Pharmacy:
Receiving / Storage / Preparation


Exposure Risk: low
• Handling/preparation PPE Requirements: Single CX gloves, gown
• Receiving from Distributor: Standard
• Pharmacy Storage Area: IV Area
• Packaging/Reconstitution Location: n/a
• Compounding (Non-Sterile/Sterile) Location: Positive pressure room
• Omnicell Load: No
Transport • Transport (dose is placed inside a plastic sealable bag): Standard
Nursing:
Storage / Administration


Exposure Risk: low
• Handling/administration PPE Requirements: Single pair of CX approved gloves. Wash hands after handling
• Storage of Finished dose in Nursing Area/Procedural Area: Patient Med Drawer
• Signage on Patient Door Required: No
• Manipulation of Dosage Form: n/a
• Special Manipulation for Administration: n/a
Disposal / Spills • Disposal of Drug Waste: Full-  black bin 
Trace-  yellow bin 
• Disposol of Used PPE: trash bin (inside plastic bag)
• Spill management: n/a
Reason for exemption of USP<800> Containment Requirements: Preg Category D. Release to the environment should be minimized per MSDS.

Last updated: May. 22, 2025
  • Renal Adjustment Policy voriconazole subject to adjustments by pharmacy.
  • Hazard.Drug Handling(USP 800) USP<800> Hazardous Drug / Assessment of Risk
  • IV to PO Conversion Policy Policy



Pharmacy Contact Info:

Main Inpatient Pharmacy: ext 4599, 3503
Fax: 704-878-7283

Director of Pharmacy - Randi Raynor, PharmD: ext 4501
Clinical Coordinator - Laura Rollings, PharmD: ext 4597
Pharmacy Informaticist - Stephen Pringle, PharmD: ext 7645
Pharmacy Technician Supervisor - Amy Wingler, CPhT: ext 7385
Pharmacy Automation Coordinator (Omnicell) - Melissa Fulford, CPhT: ext 3556



This site is intended for the staff of Iredell Health System. While others may view accessible pages, Iredell Health System makes no warranty, express or implied, as to the use of this information outside of Iredell Health System. The content of this policy and procedure document serves as guidance to the delivery of quality patient care. Care providers are expected to exercise critical thinking and situational awareness skills, and in specific situations to take such action as is necessary for the delivery of quality patient care.